Neil H. Shear

Medicine · Health Sciences

78h-index22.7kcitations615works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug-Induced Adverse Reactions(169), Autoimmune Bullous Skin Diseases(89), Urticaria and Related Conditions(69), Nail Diseases and Treatments(59), Psoriasis: Treatment and Pathogenesis(55)

Publications608 total

Class Reactions
2025
CSHP Professional Practice Conference 2025: Poster Abstracts / Conférence sur la pratique professionnelle 2025 de la SCPH : Résumés des affiches
The Canadian Journal of Hospital Pharmacy·2025Open Access
  Concordance of Synonyms and Trade Names with Generic Names
2024
Class Reactions*
2024
Responsible but Innovative Use of Artificial Intelligence in Scientific Publishing
JID Innovations·2024Open Access
Updates in SJS/TEN: collaboration, innovation, and community
Frontiers in Medicine·2023· 33 citedOpen Access
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Journal of Cutaneous Medicine and Surgery·2023· 8 citedOpen Access
Flaws and Limitations of Classification Criteria for Drug Reaction With Eosinophilia and Systemic Symptoms
The Journal of Allergy and Clinical Immunology In Practice·2023· 7 citedOpen Access
Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management
American Journal of Clinical Dermatology·2023· 72 citedOpen Access
Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
Orphanet Journal of Rare Diseases·2023· 18 citedOpen Access
A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
Biomedicines·2023· 8 citedOpen Access
Measuring h-index and scholarly productivity in academic dermatology in Canada
Scientometrics·2022· 15 citedOpen Access
Drugs That Cause Important Reactions
2022
Concordance of Synonyms and Trade Names with Generic Names
2022
Descriptions of Important Reactions
2022
Class Reactions*
2022
Main Classes of Drugs
2022
Litt's Drug Eruption & Reaction Manual
2022· 2 cited
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice
JAMA Dermatology·2022· 32 citedOpen Access
Comment on “Toxic epidermal necrolysis (TEN) after first dose of Pfizer (<scp>BNT162b2</scp>) vaccination and <scp>pharmacogenomic‐based‐point‐care</scp> support: First case report in pediatric and review of literature”
Pediatric Dermatology·2022· 1 citedOpen Access
page 1 of 31Next →

Frequent Co-authors

Simon R. Knowles(8), Nicole Mittmann(5), Michael Rieder(5), Aditya K. Gupta(4), Elizabeth J. Phillips(4), Bruce Carleton(4), Maja Mockenhaupt(3), Jack Uetrecht(3), Thomas R. Einarson(3), Wen‐Hung Chung(3), Munir Pirmohamed(3), Manuela G. Neuman(3), Harald Gollnick(2), A.Y. Finlay(2), S P Spielberg(2), Lori E. Shapiro(2), Richard C. Summerbell(2), Vincent Piguet(2), Antonellá Tosti(2), Bianca Maria Piraccini(2)